Radford Harlan Baird 4
4 · Allakos Inc. · Filed May 15, 2025
Insider Transaction Report
Form 4
Allakos Inc.ALLK
Radford Harlan Baird
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2025-05-15−163,426→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2025-05-15−27,600→ 0 totalExercise: $105.16Exp: 2031-04-19→ Common Stock (27,600 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-05-15−194,144→ 0 totalExercise: $7.20Exp: 2033-01-06→ Common Stock (194,144 underlying)
Footnotes (3)
- [F1]Includes 128,339 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
- [F2]Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
- [F3]This option was cancelled without consideration pursuant to the terms of the Merger Agreement.